National Institutes of Health, National Institute of Allergy and Infectious Diseases - December 1, 2006
December 1 marks World AIDS Day, a time to reflect on how HIV/AIDS has changed our world and an opportunity to recommit our efforts to making a difference. The Promise of Partnerships, the theme adopted by the Department of Health and Human Services, reminds us how each of us must play a critical role in the fight agai
National Institutes of Health, National Institute of Allergy and Infectious Diseases -- Wednesday, Nov. 29, 2006
Laurie K. Doepel (301) 402-1663 niaidnews@niaid.nih.gov
Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV
National Institute of Allergy and Infectious Diseases, National Institutes of Health - October 11, 2006
Media Contact: NIAID News Office, (301) 402-1663
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the launch of the Be The Generation public awareness campaign, challenging young Americans to be the generation that ends AIDS through the discovery of a safe and effective preventive HIV vaccine
National Institute of Allergy and Infectious Diseases, National Institutes of Health - October 11, 2006
Media Contact: Laurie Doepel, 301-402-1663
October 15th is the 4th Annual National Latino AIDS Awareness Day, a day to focus on the impact of HIV/AIDS in the Latino population and recommit to working together to curb the devastating effects of HIV/AIDS in this and other minority communities in the United States . It is gratifying to know that national, regional
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Friday, June 9, 2006
Media Contact: Jason Socrates Bardi, (301) 402-1663, jbardi@niaid.nih.gov
Results of two new studies sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that even if an HIV vaccine offers imperfect protection against the virus, it might provide vaccinated individuals with an important benefit: a signi
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Friday, June 2, 2006
Media Contact: Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov
Increasingly effective HIV therapy--including a decade of highly active antiretroviral therapy (HAART)--has provided 3 million years of extended life to Americans with AIDS since 1989, report researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Heal
National Institute of Allergy and Infectious Diseases, National Institutes of Health - June 1, 2006
Monday, June 5, 2006, marks the 25th anniversary of the first reported cases of what is now known as the acquired immunodeficiency syndrome (AIDS). From a handful of initial reports in the Morbidity and Mortality Weekly Report, AIDS has grown into a global pandemic affecting men, women and children in nearly every coun
National Institute of Allergy and Infectious Diseases, National Institutes of Health - May 24, 2006
On behalf of the staff of the U.S. National Institute of Allergy and Infectious Diseases at the National Institutes of Health, I would like to express deep sorrow for the loss of Dr. Lee Jong-Wook, a valued colleague and tireless crusader for the improvement of global health. Dr. Lee dedicated his life to bettering the
National Institute of Allergy and Infectious Diseases, National Institutes of Health - May 17, 2006
Today we commemorate the 2nd annual National Asian and Pacific Islander HIV/AIDS Awareness Day. This day provides an opportunity to increase public awareness of the destructive effects of HIV/AIDS on Asians and Pacific Islanders (API), and to renew our commitment to preventing the spread of HIV within all our minority
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Monday, May 15, 2006
The 9th annual HIV Vaccine Awareness Day on May 18, 2006, serves as a somber reminder of the more than 25 million people who have died of AIDS since the first cases were reported nearly 25 years ago. Although research advances have greatly extended the life expectancy of a person infected with HIV today, there is no cu
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Thursday, April 6, 2006
Media Contact: Jason Socrates Bardi, (301) 402-1663, jbardi@niaid.nih.gov
Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi s sarcoma herpesvirus (KSHV), the virus that causes Kaposi s sarcoma and certain forms of lympho
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Tuesday, March 21, 2006
Media contact: NIAID News Office, 301-402-1663, niaidnews@niaid.nih.gov
March 24, 2006 is World TB Day, which commemorates both the struggles and successes in the worldwide fight against tuberculosis, a longtime microbial adversary. TB, a global infectious disease threat, claims the lives of more than 1.7 million people each year and disables many of the 15.4 million individuals currently
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Tuesday, March 21, 2006
Media Contact: Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has updated Focus on Tuberculosis (TB) in advance of World TB Day, March 24. This Web feature describes TB research being done in NIAID s labs in Bethesda, MD, and by NIAID-supported scientists across the count
National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 8, 2006
March 10, 2006 marks the first National Women and Girls HIV/AIDS Awareness Day. This day of recognition serves to raise awareness of the increasing impact of HIV/AIDS on women and girls in the United States and throughout the world. In the early days of the pandemic, relatively few women were infected with HIV. Today,
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Monday, February 13, 2006
Media Contact: NIAID News Office, (301) 402-1663, niaidnews@nih.gov
The National Institute of Allergy and Infectious Diseases today announced the appointment of four new members to the National Advisory Allergy and Infectious Diseases Council, its principal advisory body. NIAID is part of the National Institutes of Health (NIH), an agency within the Department of Health and Human Servi
National Institute of Allergy and Infectious Diseases, National Institutes of Health - February 6, 2006
February 7th, National Black HIV/AIDS Awareness and Information Day, serves as a reminder of the disproportionate effect of HIV/AIDS on Blacks and provides an opportunity to renew our commitment to work together to end this modern plague. Fighting the spread of HIV/AIDS and reducing the toll among Blacks will require a
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Wednesday, Jan. 18, 2006
A Large International HIV/AIDS Study Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) 1. What is the SMART trial? The Strategies for Management of Anti-Retroviral Therapy (SMART) trial is a large international trial designed to determine which of two distinct HIV treatment strategies
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Wednesday, Jan. 18, 2006
Media Contact: Laurie K. Doepel, (301) 402-1663, niaidnews@niaid.nih.gov
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced that enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollme
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Tuesday, Jan. 17, 2006
Media Contact: Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov
People who lack a cell surface protein called CCR5 are highly resistant to infection by HIV but may be at increased risk of developing West Nile virus (WNV) illness when exposed to the mosquito-borne virus, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National I
This information is designed to support, not replace, the relationship that exists between you and your doctor.